Confounding by indication and the risk of hyperlipidemia in observational studies of antipsychotics.
Rico-Villademoros
Fernando
F
Calandre
Elena P
EP
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines / Q000009:adverse effects / Q000627:therapeutic use; D016022:Case-Control Studies; D015986:Confounding Factors, Epidemiologic; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced*; D000077152:Olanzapine; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine